News FDA Clears Adalimumab (Humira) for Uveitis by Medscape • 2016/07/01 • 0 Comments The approval of adalimumab for noninfectious intermediate and posterior uveitis and panuveitis marks the 10th approved indication for adalimumab in the United States. FDA Approvals Full Story →